On November 25, 2025, Chengdu Kanghua Biological Products Co Ltd announced that it had held its Extraordinary General Meeting of Shareholders on November 25, 2025, and declared the voting results. Accordingly, director nomination submitted by Shanghai Wankexin Biotechnology Partnership Wang Li as a candidate for independent director of the Company's 3rd board of directors was approved by the shareholders of the Company.